A survey of almost 400 GPs conducted by ADG on their contact with pharmaceutical field staff early in the pandemic, found a significant drop in face-to-face engagement.

This industry white paper, ‘How a GP initiated engagement model could be the way forward for the pharmaceutical industry’ shows that through the adoption of new technologies and by accepting greater GP input into when and how engagements take place, pharmaceutical company support and education will remain as relevant and important as ever to GPs.

Adg White Paper Ii Inside Healthcare 3 Pg Spread

Talk to us today!

We work with brands to understand their objectives and deliver bespoke engaging content which drives results.